5J6.F OSSDSIGN AB
- Market cap
- EUR 31.2M
- P/E
- -
- P/B
- 1.24x
- ROE
- -13.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 5J6.F undervalued?
Graham numberThe Graham number of OSSDSIGN AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
OSSDSIGN AB fundamental analysis
No fundamental analysis for OSSDSIGN AB yet.
OSSDSIGN AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About OSSDSIGN AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.
Full company profileOSSDSIGN AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
OSSDSIGN AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 57.0M | 112M | 134M | 180M | 147M |
| Gross Profit | 35.0M | 83.6M | 128M | 173M | 136M |
| Operating Income | -96.9M | -92.0M | -49.4M | -48.3M | -43.6M |
| EBITDA | -80.5M | -103M | -42.0M | -46.0M | -43.6M |
| Net Income | -99.4M | -130M | -49.7M | -51.0M | -38.2M |
| EPS | -1.39 | -1.34 | -0.51 | -0.46 | -0.35 |
| Balance Sheet | |||||
| Total Assets | 340M | 356M | 307M | 398M | 358M |
| Total Liabilities | 91.4M | 105M | 93.4M | 87.8M | 75.4M |
| Shareholders' Equity | 248M | 251M | 214M | 310M | 283M |
| Cash & Short-term Investments | 125M | 166M | 101M | 191M | 138M |
| Cash Flow | |||||
| Operating Cash Flow | -86.2M | -93.9M | -62.4M | -64.0M | -42.6M |
| Capital Expenditure | 129K | 124K | 657K | 7.40M | 29.1M |
| Free Cash Flow | -86.3M | -94.0M | -63.0M | -71.4M | -71.7M |
| Ratios | |||||
| ROE | -40.1% | -52.0% | -23.2% | -16.4% | -13.5% |
| ROA | -29.3% | -36.6% | -16.2% | -12.8% | -10.7% |
| Net Profit Margin | -174.4% | -116.3% | -37.1% | -28.3% | -26.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
OSSDSIGN AB dividends
OSSDSIGN AB has not paid dividends in the last 4 fiscal years.
Who owns OSSDSIGN AB
- Insiders 21.05%
- Institutions 37.96%
- Public & others 41.00%
- Shares outstanding 111M
- Free float 78.1M
OSSDSIGN AB company profile
- Company name
- OSSDSIGN AB
- Ticker
- 5J6.F
- ISIN
- SE0012570448
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 38
- Fiscal year end
- December
- Address
- Ulls väg 29C, Uppsala, Sweden, 756 51
- Phone
- 46 1 84 30 81 10
- Website
- ossdsign.com
About OSSDSIGN AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.
OSSDSIGN AB management
7- Mr. Mark Waugh B.S., M.B.A.Chief Executive Officer
- Mr. Anders SvenssonChief Financial Officer · born 1963
- Dr. Tom Buckland Ph.D.Chief Technical Officer · born 1972
- Mr. Stephen AndersonVice President of Marketing · born 1976
- Mr. Adam McCollisterVice President of Sales
- Ms. Melanie MarshallVice President of Clinical & Medical Affairs · born 1979
- Mr. Eric PatermoVice President of Sales US · born 1969